Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

J Wesson Ashford^{1

2

3}, Frederick A Schmitt^{3

4}, Michael F Bergeron⁵, Peter J Bayley^{1

2

3}, James O Clifford⁶, Qun Xu⁷, Xiaolei Liu^{8

9}, Xianbo Zhou^{10

11}, Vinod Kumar¹², Herman Buschke^{3

13}, Margaret Dean^{3

14}, Sanford I Finkel^{3

15}, Lee Hyer^{3

16}, George Perry^{3

17}

Affiliations

¹ War Related Illness and Injury Study Center, VA Palo Alto HCS, Palo Alto, CA, USA.
² Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
³ Medical, Scientific, Memory Screening Advisory Board, Alzheimer's Foundation of American (AFA), New York, USA.
⁴ Departments of Neurology, Psychiatry, Neurosurgery, Psychology, Behavioral Science; Sanders-Brown Center on Aging, Spinal Cord & Brain Injury Research Center, University of Kentucky, Sanders-Brown Center on Aging, Lexington, KY, USA.
⁵ SIVOTEC Analytics, Boca Raton, FL, USA.
⁶ College of San Mateo, San Mateo, CA, USA.
⁷ Health Management Center, Department of Neurology, Renji Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁸ Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
⁹ Yunnan Provincial Clinical Research Center for Neurological Diseases, Yunnan, China.
¹⁰ Center for Alzheimer's Research, Washington Institute of Clinical Research, Vienna, VA, USA.
¹¹ Zhongze Therapeutics, Shanghai, China.
¹² University of Illinois, Chicago, IL, USA.
¹³ The Saul R. Korey Department of Neurology and Dominick P. Purpura Department of Neuroscience, Lena and Joseph Gluck Distinguished Scholar in Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
¹⁴ Geriatric Division, Internal Medicine, Texas Tech Health Sciences Center, Amarillo, TX, USA.
¹⁵ University of Chicago Medical School, Chicago, IL, USA.
¹⁶ Gateway Behavioral Health, Mercer University, School of Medicine, Savannah, GA, USA.
¹⁷ Brain Health Consortium, Department Biology and Chemistry, University of Texas at San Antonio, San Antonio, TX, USA.

PMID: 35431257
DOI: 10.3233/JAD-220211

Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

J Wesson Ashford et al. J Alzheimers Dis. 2022.

. 2022;87(1):305-315.

doi: 10.3233/JAD-220211.

Authors

Affiliations

¹ War Related Illness and Injury Study Center, VA Palo Alto HCS, Palo Alto, CA, USA.
² Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
³ Medical, Scientific, Memory Screening Advisory Board, Alzheimer's Foundation of American (AFA), New York, USA.
⁴ Departments of Neurology, Psychiatry, Neurosurgery, Psychology, Behavioral Science; Sanders-Brown Center on Aging, Spinal Cord & Brain Injury Research Center, University of Kentucky, Sanders-Brown Center on Aging, Lexington, KY, USA.
⁵ SIVOTEC Analytics, Boca Raton, FL, USA.
⁶ College of San Mateo, San Mateo, CA, USA.
⁷ Health Management Center, Department of Neurology, Renji Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁸ Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
⁹ Yunnan Provincial Clinical Research Center for Neurological Diseases, Yunnan, China.
¹⁰ Center for Alzheimer's Research, Washington Institute of Clinical Research, Vienna, VA, USA.
¹¹ Zhongze Therapeutics, Shanghai, China.
¹² University of Illinois, Chicago, IL, USA.
¹³ The Saul R. Korey Department of Neurology and Dominick P. Purpura Department of Neuroscience, Lena and Joseph Gluck Distinguished Scholar in Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
¹⁴ Geriatric Division, Internal Medicine, Texas Tech Health Sciences Center, Amarillo, TX, USA.
¹⁵ University of Chicago Medical School, Chicago, IL, USA.
¹⁶ Gateway Behavioral Health, Mercer University, School of Medicine, Savannah, GA, USA.
¹⁷ Brain Health Consortium, Department Biology and Chemistry, University of Texas at San Antonio, San Antonio, TX, USA.

PMID: 35431257
DOI: 10.3233/JAD-220211

Abstract

Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer's disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.

Keywords: Alzheimer’s disease; MemTrax; Mini-Mental State Examination; Montreal Cognitive Assessment; cognition assessment; computerized testing; neuroplasticity.

PubMed Disclaimer

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- IOS Press
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

Affiliations

Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

Authors

Affiliations

Abstract

MeSH terms

LinkOut - more resources

Full Text Sources

Medical